30 April 2021 – To lessen the Philippines’ dependence on vaccine importation, the Anti-Red Tape Authority (ARTA) and four key agencies will issue a Joint Memorandum Circular (JMC) to institutionalize the green lane for local vaccine manufacturers in a bid to meet the crucial demand for COVID-19 jabs. ARTA will spearhead the circular’s implementation with.. read more
ARTA urges FDA to complete green lane for local COVID-19 vaccine manufacturers within 7 days
23 April 2021 – Following President Rodrigo Duterte’s directive to set up a green lane for faster permit processing of local COVID-19 vaccine manufacturers to reduce dependency on imported jabs, Anti-Red Tape Authority (ARTA) Director General Jeremiah Belgica urged the Food and Drug Administration (FDA) to target its completion within seven (7) working days. The.. read more
Statement of the Anti-Red Tape Authority on FDA’s Issuance of LTO to Ivermectin Compounder Dr. Allan Landrito
Following our insistent calls to expedite the processing of permit applications, the Anti-Red Tape Authority (ARTA) is pleased to learn that the Food and Drug Administration (FDA) has issued a License to Operate (LTO) for medicine trading to Dr. Allan Landrito, a vocal proponent of using Ivermectin to treat COVID-19. ARTA was informed about this.. read more
Statement of the Anti-Red Tape Authority on FDA’s Granting of Compassionate Special Permit to a Hospital for use of Ivermectin on Covid-19 patients
The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19. With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies.. read more
ARTA asks FDA to keep their communications open for Ivermectin applications
31 March 2021 – Anti-Red Tape Authority (ARTA) Director General Jeremiah Belgica, in a meeting earlier, called on the Food and Drug Administration (FDA) to “keep their communications open for the registration of pharmaceutical companies who would want to apply for a Drug Emergency Use or a Compassionate Special Permit for Ivermectin”. During the meeting,.. read more